DAVITA INC. Proceeds from Sale of Productive Assets
DAVITA INC. (DVA) reported Proceeds from Sale of Productive Assets of $150.21 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-22.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfProductiveAssets · last filed 2019-02-22
- DAVITA INC. proceeds from sale of productive assets for the quarter ending 2015-03-31 was $2.56M, a 4480.36% increase year-over-year.
- DAVITA INC. proceeds from sale of productive assets for the quarter ending 2014-12-31 was $5.17M.
- DAVITA INC. proceeds from sale of productive assets for the quarter ending 2014-09-30 was $3.40M.
- DAVITA INC. proceeds from sale of productive assets for the quarter ending 2014-06-30 was $159.00K, a 92.07% decline year-over-year.
- DAVITA INC. proceeds from sale of productive assets for fiscal 2018 was $150.21M, a 62.67% increase from fiscal 2017.
- DAVITA INC. proceeds from sale of productive assets for fiscal 2017 was $92.34M, a 42.66% increase from fiscal 2016.
- DAVITA INC. proceeds from sale of productive assets for fiscal 2016 was $64.72M, a 228.30% increase from fiscal 2015.
- DAVITA INC. proceeds from sale of productive assets for fiscal 2015 was $19.71M, a 124.26% increase from fiscal 2014.
| Period end | Proceeds from Sale of Productive Assets 3 month | Proceeds from Sale of Productive Assets 6 month | Proceeds from Sale of Productive Assets 9 month | Proceeds from Sale of Productive Assets 12 month |
|---|---|---|---|---|
| 2018-12-31 | $150.21M 10-K · filed 2019-02-22 | |||
| 2017-12-31 | $92.34M 10-K · filed 2018-02-23 | |||
| 2016-12-31 | $64.72M 10-K · filed 2017-02-24 | |||
| 2015-12-31 | $19.71M 10-K · filed 2016-02-26 | |||
| 2015-03-31 | $2.56M 10-Q/A · filed 2015-05-08 | $7.74M derived: sum of 2 quarters · filed 2016-02-26 | $11.14M derived: sum of 3 quarters · filed 2016-02-26 | $11.30M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-12-31 | $5.17M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $8.58M derived: sum of 2 quarters · filed 2016-02-26 | $8.73M derived: sum of 3 quarters · filed 2016-02-26 | $8.79M 10-K · filed 2016-02-26 |
| 2014-09-30 | $3.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $3.56M derived: sum of 2 quarters · filed 2014-11-06 | $3.62M 10-Q · filed 2014-11-06 | $3.60M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $159.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2014-08-01 | $215.00K 10-Q · filed 2014-08-01 | $191.00K derived: sum of 3 quarters · filed 2016-02-26 | -$1.89M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $56.00K 10-Q/A · filed 2015-05-08 | $32.00K derived: sum of 2 quarters · filed 2016-02-26 | -$2.05M derived: sum of 3 quarters · filed 2016-02-26 | -$43.00K derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | -$24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | -$2.10M derived: sum of 2 quarters · filed 2016-02-26 | -$99.00K derived: sum of 3 quarters · filed 2016-02-26 | $62.26M 10-K · filed 2016-02-26 |
| 2013-09-30 | -$2.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$75.00K derived: sum of 2 quarters · filed 2014-11-06 | $62.28M 10-Q · filed 2014-11-06 | $63.72M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | $2.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $64.36M 10-Q · filed 2014-08-01 | $65.80M derived: sum of 3 quarters · filed 2015-02-26 | $65.90M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | $62.36M 10-Q · filed 2014-05-02 | $63.80M derived: sum of 2 quarters · filed 2015-02-26 | $63.89M derived: sum of 3 quarters · filed 2015-02-26 | $65.09M derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $1.54M derived: sum of 2 quarters · filed 2015-02-26 | $2.73M derived: sum of 3 quarters · filed 2015-02-26 | $3.56M 10-K · filed 2015-02-26 |
| 2012-09-30 | $95.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $1.29M derived: sum of 2 quarters · filed 2013-11-06 | $2.12M 10-Q · filed 2013-11-06 | $25.68M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-06-30 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $2.02M 10-Q · filed 2013-08-07 | $25.58M derived: sum of 3 quarters · filed 2014-02-21 | $74.25M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-03-31 | $825.00K 10-Q · filed 2013-05-09 | $24.39M derived: sum of 2 quarters · filed 2014-02-21 | $73.05M derived: sum of 3 quarters · filed 2014-02-21 | $73.20M derived: sum of 4 quarters · filed 2014-02-21 |
| 2011-12-31 | $23.56M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $72.23M derived: sum of 2 quarters · filed 2014-02-21 | $72.37M derived: sum of 3 quarters · filed 2014-02-21 | $75.18M 10-K · filed 2014-02-21 |
| 2011-09-30 | $48.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-31 | $48.81M derived: sum of 2 quarters · filed 2012-10-31 | $51.62M 10-Q · filed 2012-10-31 | $55.88M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | $142.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $2.95M 10-Q · filed 2012-08-03 | $7.21M derived: sum of 3 quarters · filed 2013-03-01 | $8.00M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-03-31 | $2.81M 10-Q · filed 2012-05-02 | $7.07M derived: sum of 2 quarters · filed 2013-03-01 | $7.86M derived: sum of 3 quarters · filed 2013-03-01 | $9.28M derived: sum of 4 quarters · filed 2013-03-01 |
| 2010-12-31 | $4.26M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $5.05M derived: sum of 2 quarters · filed 2013-03-01 | $6.46M derived: sum of 3 quarters · filed 2013-03-01 | $22.73M 10-K · filed 2013-03-01 |
| 2010-09-30 | $790.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $2.21M derived: sum of 2 quarters · filed 2011-11-04 | $18.47M 10-Q · filed 2011-11-04 | $19.91M derived: sum of 4 quarters · filed 2012-07-06 |
| 2010-06-30 | $1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | $17.68M 10-Q · filed 2011-08-04 | $19.12M derived: sum of 3 quarters · filed 2012-07-06 | $19.59M derived: sum of 4 quarters · filed 2012-07-06 |
| 2010-03-31 | $16.26M 10-Q · filed 2011-05-06 | $17.70M derived: sum of 2 quarters · filed 2012-07-06 | $18.18M derived: sum of 3 quarters · filed 2012-07-06 | $19.76M derived: sum of 4 quarters · filed 2012-07-06 |
| 2009-12-31 | $1.44M derived: 8-K 12 month − 10-Q 9 month · filed 2012-07-06 | $1.91M derived: sum of 2 quarters · filed 2012-07-06 | $3.50M derived: sum of 3 quarters · filed 2012-07-06 | $7.70M 8-K · filed 2012-07-06 |
| 2009-09-30 | $472.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | $2.06M derived: sum of 2 quarters · filed 2010-11-05 | $6.26M 10-Q · filed 2010-11-05 | $6.33M derived: sum of 4 quarters · filed 2011-02-25 |
| 2009-06-30 | $1.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-05 | $5.78M 10-Q · filed 2010-08-05 | $5.86M derived: sum of 3 quarters · filed 2011-02-25 | $6.19M derived: sum of 4 quarters · filed 2011-02-25 |
| 2009-03-31 | $4.20M 10-Q · filed 2010-05-03 | $4.28M derived: sum of 2 quarters · filed 2011-02-25 | $4.60M derived: sum of 3 quarters · filed 2011-02-25 | |
| 2008-12-31 | $79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $405.00K derived: sum of 2 quarters · filed 2011-02-25 | $530.00K 10-K · filed 2011-02-25 | |
| 2008-09-30 | $326.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05 | $451.00K 10-Q · filed 2009-11-05 | ||
| 2008-06-30 | $125.00K 10-Q · filed 2009-08-07 | |||
| 2007-12-31 | $12.29M 10-K · filed 2010-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |